Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Stocks / Halozyme Therapeutics Inc
Institutional Holders · Q2 2026

Who owns Halozyme Therapeutics Inc?

HALOCUSIP 40637HAD1
52
Institutions holding · +13.0% QoQ
$234M
Aggregate reported value · +9.7%
19.3M
Shares held (SH)
Top 50
The holders

Twelve quarters of conviction

Aggregate reported value (bars) against the number of institutions holding (line).
Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26

The holders

Top 11 of 52 institutions, ranked by reported value. Share change is versus the manager’s previous filing.
#ManagerSharesShare Δ QoQValue% of book
1Tpg Gp A, Llc10.0M+0.0%$11M0.2%
2Rational Advisors, Inc.5.1M+72.1%$6M0.5%
3Focus Partners Wealth3.7M−1.1%$4M0.0%
4Laffer Tengler Investments, Inc.1,931—$2M0.3%
5Oppenheimer Asset Management Inc.173,000+1.8%$192,2200.0%
6&Partners130,000+0.0%$144,4430.0%
7Mariner, LLC59,000+0.0%$65,7290.0%
8Stephens Inc /Ar/53,000+0.0%$58,8880.0%
9Commonwealth Equity Services, Llc17,000−15.0%$18,8810.0%
10Cetera Investment Advisers12,000+0.0%$13,3330.0%
11Lanark Financial, Inc.8,000—$8,8880.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.